230 related articles for article (PubMed ID: 25624445)
1. Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence.
Nakagawa MM; Thummar K; Mandelbaum J; Pasqualucci L; Rathinam CV
J Exp Med; 2015 Feb; 212(2):203-16. PubMed ID: 25624445
[TBL] [Abstract][Full Text] [Related]
2. A20 deficiency in multipotent progenitors perturbs quiescence of hematopoietic stem cells.
Nakagawa MM; Davis H; Rathinam CV
Stem Cell Res; 2018 Dec; 33():199-205. PubMed ID: 30445411
[TBL] [Abstract][Full Text] [Related]
3. Acquired deficiency of A20 results in rapid apoptosis, systemic inflammation, and abnormal hematopoietic stem cell function.
Nagamachi A; Nakata Y; Ueda T; Yamasaki N; Ebihara Y; Tsuji K; Honda Z; Takubo K; Suda T; Oda H; Inaba T; Honda H
PLoS One; 2014; 9(1):e87425. PubMed ID: 24498102
[TBL] [Abstract][Full Text] [Related]
4. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.
Hövelmeyer N; Reissig S; Xuan NT; Adams-Quack P; Lukas D; Nikolaev A; Schlüter D; Waisman A
Eur J Immunol; 2011 Mar; 41(3):595-601. PubMed ID: 21341261
[TBL] [Abstract][Full Text] [Related]
5. A20 deficiency in hematopoietic stem cells causes lymphopenia and myeloproliferation due to elevated Interferon-γ signals.
Nakagawa MM; Rathinam CV
Sci Rep; 2019 Sep; 9(1):12658. PubMed ID: 31477755
[TBL] [Abstract][Full Text] [Related]
6. A20 and CYLD do not share significant overlapping functions during B cell development and activation.
Chu Y; Soberon V; Glockner L; Beyaert R; Massoumi R; van Loo G; Krappmann D; Schmidt-Supprian M
J Immunol; 2012 Nov; 189(9):4437-43. PubMed ID: 23002441
[TBL] [Abstract][Full Text] [Related]
7. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
Turer EE; Tavares RM; Mortier E; Hitotsumatsu O; Advincula R; Lee B; Shifrin N; Malynn BA; Ma A
J Exp Med; 2008 Feb; 205(2):451-64. PubMed ID: 18268035
[TBL] [Abstract][Full Text] [Related]
8. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
9. Slicer Endonuclease Argonaute 2 Is a Negative Regulator of Hematopoietic Stem Cell Quiescence.
Lu K; Nakagawa MM; Thummar K; Rathinam CV
Stem Cells; 2016 May; 34(5):1343-53. PubMed ID: 26850790
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.
Kool M; van Loo G; Waelput W; De Prijck S; Muskens F; Sze M; van Praet J; Branco-Madeira F; Janssens S; Reizis B; Elewaut D; Beyaert R; Hammad H; Lambrecht BN
Immunity; 2011 Jul; 35(1):82-96. PubMed ID: 21723156
[TBL] [Abstract][Full Text] [Related]
11. A20 deficiency causes spontaneous neuroinflammation in mice.
Guedes RP; Csizmadia E; Moll HP; Ma A; Ferran C; da Silva CG
J Neuroinflammation; 2014 Jul; 11():122. PubMed ID: 25026958
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
13. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
15. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
16. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.
Tesio M; Tang Y; Müdder K; Saini M; von Paleske L; Macintyre E; Pasparakis M; Waisman A; Trumpp A
J Exp Med; 2015 Apr; 212(4):525-38. PubMed ID: 25824820
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome.
Mc Guire C; Rahman M; Schwaninger M; Beyaert R; van Loo G
Cell Death Dis; 2013 Mar; 4(3):e531. PubMed ID: 23470538
[No Abstract] [Full Text] [Related]
20. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
